ArticlePharmacoEconomics2017

Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis.

James Buchanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.